| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.48 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.17 | 0.06 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.07 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |